Cartesian Therapeutics Announces New Employment Inducement Grants
GAITHERSBURG, Md.--(BUSINESS WIRE)--May 6, 2024--
Source: eagletribune.com
Ron Moldaver News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ron Moldaver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ron Moldaver Today - Breaking & Trending Today
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – –...
Source: marketscreener.com
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to Editas Medicine's Fourth Quarter and Full-year 2022 Conference Call. All participants are now in a listen-only mode.
Source: insidermonkey.com
Editas Medicine Announces Fourth Quarter and Full Year 2022
Commenced parallel patient dosing in the EDIT-301 RUBY trial for SCD, following clinical proof-of-concept demonstrated last quarter On track to provide...
Source: globenewswire.com
Editas Medicine Announces Clinical Achievements in the Development of EDIT-301 for Sickle Cell Disease
Successful engraftment of first patient dosed with EDIT-301 for sickle cell disease FDA removed partial clinical hold for the RUBY trial in EDIT-301 First clinical use of Editas-engineered... | July 27, 2022
Source: marketscreener.com